TY - JOUR U1 - Wissenschaftlicher Artikel A1 - Rauh, Ulrike A1 - Wei, Guo A1 - Serrano-Wu, Michael A1 - Kosmidis, Georgios A1 - Kaulfuss, Stefan A1 - Siegel, Franziska A1 - Thede, Kai A1 - McFarland, James A1 - Lemke, Christopher T. A1 - Werbeck, Nicolas D. A1 - Nowak-Reppel, Katrin A1 - Pilari, Sabine A1 - Menz, Stephan A1 - Ocker, Matthias A1 - Zhang, Weiqun A1 - Davis, Kyle A1 - Poncet-Montange, Guillaume A1 - Roth, Jennifer A1 - Daniels, Douglas A1 - Kaushik, Virendar K. A1 - Hubbard, Brian A1 - Ziegelbauer, Karl A1 - Golub, Todd R. T1 - BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models JF - Nature Cancer Y1 - 2024 SN - 2662-1347 SS - 2662-1347 U6 - https://doi.org/10.1038/s43018-024-00814-0 DO - https://doi.org/10.1038/s43018-024-00814-0 VL - 5.2024 IS - 10 SP - 1479 EP - 1493 ER -